Freenome, Inc.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Freenome
Services-Medical Laboratories, SIC 8071
Perceptive Capital Solutions Corp operates as a blank check company established to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity does not manufacture commercial products, offer services, or maintain distinct operating business segments. Because it functions as an acquisition vehicle rather than an operating commercial enterprise, the company does not serve commercial clients or retail consumers. Instead, its core business activity centers on identifying, evaluating, and negotiating a potential initial transaction with private or public operating enterprises, concentrating primarily on companies within the healthcare sector, specifically life sciences and medical technology.
The organization maintains its principal executive offices in New York, New York, and is organized as an exempted company under the laws of the Cayman Islands. As a shell entity without commercial operations, it owns no stores or manufacturing plants. Geographically, its acquisition focus spans prospective corporate targets located in North America and Europe.
Summary of the business section of Freenome's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Freenome, Inc.
- Founded
- 2024
- Headquarters
- Brisbane, CA
- Address
- Genesis Marina, 3300 Marina Blvd 94005
- Phone
- (212) 284-2300
- Employees
- 19, Dec 31, 2025
- Industry
- Services-Medical Laboratories
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- WithumSmith+Brown, PC, New York, New York
Stock & identifiers
- Ticker
- FRNM
- Exchange
- Nasdaq
- IPO date
- Jun 12, 2024
- Shares outstanding
- 10M, Jul 15, 2026
- Public float
- $91.60M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2017526
- CUSIP
- 35661P100
- ISIN
- US35661P1003
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Aaron Matthew Elliott | Chief Executive Officer, Director | 345,976 |
| Riley Charles Ennis | Chief Product Officer | 2,864,366 |
| Cheng-Ho Jimmy Lin | Chief Scientific Officer | 410,154 |
| Linh H. Le | Chief Financial Officer | 64,294 |
| Deepika Pakianathan | Director | 13,918 |
| Randal W. Scott | Director | 104,204 |
| Oort Douglas M. Van | Director | 20,867 |
| Ann Catherine Costello | Director | – |
| Carole Nuechterlein | Director | – |
| Capital Healthcare Fund LP RA | Director | – |
| Rajeev M. Shah | Director | 750,000 |
| RA Capital Nexus Fund III, L.P. | Director | – |
| Peter Kolchinsky | Director | – |
| RA Capital Nexus Fund, L.P. | Director | 1,245,068 |
| Ra Capital Management, L.P. | Director | – |
| RA Capital Nexus Fund II, L.P. | Director | – |
Employees
Headcount reported in annual reports
“● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; … ● our ability to consummate an initial business combination, including the Proposed Freenome Business Combination, due to the uncertainty resulting from geopolitical tensions or conflicts such as the ongoing conflicts between Russia and Ukraine, Israel and Iran, and Israel and Hamas, acts of war or terrorism, economic impacts such as inflation, ”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 13, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 24, 2026 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jul 24, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 20, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jul 20, 2026 | Delisting | Notice of delisting from exchange (Form 25) |
| Jul 15, 2026 | Name change | Name changed from Perceptive Capital Solutions Corp to Freenome, Inc. |
| Apr 28, 2026 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Jun 12, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 10, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |